Search

everythinglearnresearchcommunity

for

Search:↓

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Spironolactone is effective and safe for treating excessive facial hair in women.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.